Synergy as a rationale for phage therapy using phage cocktails

PeerJ

Volumn 2014, Issue 1, 2014, Pages

  Schmerer, Matthew ^a   Molineux, Ian J ^a   Bull, James J ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Bacteria; Biofilm; Depolymerase; Dynamics; Models; Phage therapy

Indexed keywords

BACTERIAL PROTEIN; COLANIDASE; TAILSPIKE PROTEIN; UNCLASSIFIED DRUG;

ANTIBIOSIS; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIOPHAGE; CELL VIABILITY ASSAY; COMPUTER SIMULATION; CONTROLLED STUDY; DNA SEQUENCE; ESCHERICHIA COLI; FLOW CYTOMETRY; MATHEMATICAL MODEL; MICROBIAL POPULATION DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGE COCKTAIL; PHENOTYPE; SENSITIVITY ANALYSIS;

EID: 84908137427     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.590     Document Type: Article

References (29)

1. Adams MH. 1959. Bacteriophages. New York: Interscience Publishers.
2. Adriaenssens EM, Ceyssens P-J, Dunon V, Ackermann H-W, Van Vaerenbergh J,Maes M, De Proft M, Lavigne R. 2011. Bacteriophages LIMElight and LIMEzero of pantoea agglomerans, belonging to the "phiKMV-like viruses". Applied and Environmental Microbiology 77(10):3443-3450 DOI 10.1128/AEM.00128-11.
3. Azeredo J, Sutherland IW. 2008. The use of phages for the removal of infectious biofilms. Current Pharmaceutical Biotechnology 9(4):261-266 DOI 10.2174/138920108785161604.
4. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL,Mori H. 2006. Construction of Escherichia coli k-12 in-frame, single-gene knockout mutants: the keio collection. Molecular Systems Biology 2:2006.0008 DOI 10.1038/msb4100050.
5. Bessler W, Fehmel F, Freund-Mölbert E, Knüfermann H, StirmS. 1975. Escherichia coli capsule bacteriophages. IV. Free capsule depolymerase 29. Journal of Virology 15(4):976-984.
6. Bull JJ,Molineux IJ. 2008. Predicting evolution from genomics: experimental evolution of bacteriophage t7. Heredity 100(5):453-463 DOI 10.1038/sj.hdy.6801087.
7. Bull JJ, Vegge CS, Schmerer M, Chaudhry WN, Levin BR. 2014. Phenotypic resistance and the dynamics of bacterial escape from phage control. PLoS ONE 9(4):e94690 DOI 10.1371/journal.pone.0094690.
8. Bull JJ, Vimr ER,Molineux IJ. 2010. A tale of tails: sialidase is key to success in a model of phage therapy against k1-capsulated Escherichia coli. Virology 398(1):79-86 DOI 10.1016/j.virol.2009.11.040.
9. Chan BK, Abedon ST, Loc-Carrillo C. 2013. Phage cocktails and the future of phage therapy. Future Microbiology 8(6):769-783 DOI 10.2217/fmb.13.47.
10. Cornelissen A, Ceyssens P, T'Syen J, Van Praet H, Noben J, Shaburova OV, Krylov VN, Volckaert G, Lavigne R. 2011. The T7-related Pseudomonas putida phage f15 displays virion-associated biofilm degradation properties. PLoS ONE 6(4):e18597 DOI 10.1371/journal.pone.0018597.
11. Delbruck M. 1945. Interference between bacterial viruses: III. The mutual exclusion effect and the depressor effect. Journal of Bacteriology 50:151-170.
12. Dunn JJ, Studier FW. 1983. Complete nucleotide sequence of bacteriophage t7 DNA and the locations of t7 genetic elements. Journal of Molecular Biology 166(4):477-535 DOI 10.1016/S0022-2836(83)80282-4.
13. Firozi P, Zhang W, Chen L, Quiocho FA,Worley KC, Templeton NS. 2010. Identification and removal of colanic acid from plasmid DNA preparations: implications for gene therapy. Gene Therapy 17(12):1484-1499 DOI 10.1038/gt.2010.97.
14. Garíia LR,Molineux IJ. 1995. Rate of translocation of bacteriophage T7 DNA across the membranes of Escherichia coli. Journal of Bacteriology 177(14):4066-4076.
15. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C,Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JYH, Zhang J. 2004. Bioconductor: open software development for computational biology and bioinformatics. Genome Biology 5(10):R80 DOI 10.1186/gb-2004-5-10-r80.
16. Gill JJ, Hyman P. 2010. Phage choice, isolation, and preparation for phage therapy. Current Pharmaceutical Biotechnology 11(1):2-14 DOI 10.2174/138920110790725311.
17. Gladstone EG,Molineux IJ, Bull JJ. 2012. Evolutionary principles and synthetic biology: avoiding a molecular tragedy of the commons with an engineered phage. Journal of Biological Engineering 6(1):13 DOI 10.1186/1754-1611-6-13.
18. Hanlon GW, Denyer SP, Olliff CJ, Ibrahim LJ. 2001. Reduction in exopolysaccharide viscosity as an aid to bacteriophage penetration through Pseudomonas aeruginosa biofilms. Applied and Environmental Microbiology 67(6):2746-2753 DOI 10.1128/AEM.67.6.2746-2753.2001.
19. Heineman RH, Bull JJ. 2007. Testing optimality with experimental evolution: lysis time in a bacteriophage. Evolution 61(7):1695-1709 DOI 10.1111/j.1558-5646.2007.00132.x.
20. Hughes KA, Sutherland IW, Clark J, Jones MV. 1998. Bacteriophage and associated polysaccharide depolymerases-novel tools for study of bacterial biofilms. Journal of Applied Microbiology 85(3):583-590 DOI 10.1046/j.1365-2672.1998.853541.x.
21. Kassa T, Chhibber S. 2012. Thermal treatment of the bacteriophage lysate of klebsiella pneumoniae b5055 as a step for the purification of capsular depolymerase enzyme. Journal of Virological Methods 179(1):135-141 DOI 10.1016/j.jviromet.2011.10.011.
22. Levin BR, Stewart FM, Chao L. 1977. Resource-limited growth, competition, and predation-a model and experimental studies with bacteria and bacteriophage. American Naturalist 111(977):3-24 DOI 10.1086/283134.
23. Lu TK, Collins JJ. 2007. Dispersing biofilms with engineered enzymatic bacteriophage. PNAS 104(27):11197-11202 DOI 10.1073/pnas.0704624104.
24. Merabishvili M, Pirnay JP, Verbeken G, Chanishvili N, Tediashvili M, Lashkhi N, Glonti T, Krylov V, Mast J, Van Parys L, Lavigne R, Volckaert G,Mattheus W, Verween G, De Corte P, Rose T, Jennes S, Zizi M, De Vos D, Vaneechoutte M. 2009. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS ONE 4(3):e4944 DOI 10.1371/journal.pone.0004944.
25. Mushtaq N, Redpath MB, Luzio JP, Taylor PW. 2004. Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype. Antimicrobial Agents and Chemotherapy 48(5):1503-1508 DOI 10.1128/AAC.48.5.1503-1508.2004.
26. R Development Core Team. 2012. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing.
27. Sutherland IW. 1971. Enzymic hydrolysis of colanic acid. European Journal of Biochemistry 23(3):582-587 DOI 10.1111/j.1432-1033.1971.tb01657.x.
28. Sutherland IW. 1995. Polysaccharide lyases. FEMS Microbiology Reviews 16(4):323-347 DOI 10.1111/j.1574-6976.1995.tb00179.x.
29. Warren RL, Sutton GG, Jones SJM, Holt RA. 2007. Assembling millions of short DNA sequences using SSAKE. Bioinformatics 23(4):500-501 DOI 10.1093/bioinformatics/btl629.